3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Recurrence
1
Nasopharyngeal Carcinoma
1
Interventions
Surgical Procedures, Operative
2
Dexamethasone
2
temoporfin
1
pomalidomide
1
pembrolizumab
1
nimotuzumab
1
liposomal doxorubicin
1
ledipasvir
1
ibrutinib
1
golimumab
1
Vinorelbine
1
Tomography, X-Ray Computed
1
Thalidomide
1
Sofosbuvir
1
Rituximab
1
Ribavirin
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mitoxantrone
1
Mastectomy
1
Irinotecan
1
Infliximab
1
Immunotherapy, Adoptive
1
Hematologic Tests
1
Drug Therapy
1
Docetaxel
1
Diagnostic Imaging
1
Dermoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Recurrence
×
temoporfin
×
Clear all
NCT01086488
2011-07-08
FOSCAN
Ministry of Health, Malaysia
Phase 2
Unknown
66 enrolled